Human trials of a potential vaccine for the Covid-19 coronavirus are set to begin in Britain this week.
"It was chosen as the most suitable vaccine technology for a SARS-CoV-2 (COVID-19) vaccine as it can generate a strong immune response from one dose and it is not a replicating virus, so it cannot cause an ongoing infection in the vaccinated individual", it added.
The Oxford University project, a collaboration between the university's Jenner Institute and Oxford Vaccine Group, opened recruitment for the clinical trial - for healthy adults between 18 and 55 - at the end of March, having begun research on a vaccine against the coronavirus-borne disease COVID-19 in February.
"We have put more money than any other country into a global search for a vaccine and, for all the efforts around the world, two of the leading vaccine developments are taking place here at home - at Oxford and Imperial", he said.
Hancock said his team is prepared to "throw everything we've got at developing a vaccine" and expressed effusive support for researchers at Oxford and Imperial. "Vaccine development is a process of trial and error-and trial again".
The Government will give the scientists in Oxford an extra £20million to help with their trials, Mr Hancock said, and a further £22.5m to a project at Imperial College London.
China said its now developing 3 vaccines for the novel coronavirus.
United Kingdom coronavirus lockdown extended for at least three weeks
Mr Raab said relaxing the lockdown would risk a significant increase in the spread of coronavirus . Lockdown will continue for another three weeks.
Iranian vessels practices attacks on U.S. Military ships in Arabian Gulf
The guns do not appear to be pointed at the ship, which sounds a horn multiple times as the Iranian vessels approach. Iran retaliated on 8 January with a rocket attack on Iraq's Ain al-Assad base where U.S. forces were stationed.
E competition: Chauncey Billups shocks Trae Young to open tournament
In the first round, Trae Young hoisted a bunch of left handed free-throws, but he didn't seem to have many ideas beyond that. The 2004 NBA Finals MVP defeated Atlanta Hawks point guard Trae Young to advance to the next round.
More than 70 vaccines are now in development by research teams around the world, according to a report by the World Health Organization last week.
At the same time, we'll invest in manufacturing capability so if either of these vaccines safely works then we can make it available for the British people as soon as humanely possible.
The planned tests were announced by UK's secretary for Health, Matt Hancock, who however cautioned that "nothing about this process is certain".
The vaccine being trialled is called ChAdOx1 nCoV-19 and is made from a weakened version of a common cold virus (adenovirus) from chimpanzees that has been genetically changed so that it is impossible for it to grow in humans.
Meanwhile, a total of 17,337 people who tested positive for coronavirus have died in hospitals in Britain, an increase of 828 on the figure published 24 hours earlier, health ministry data showed.
In reference to a major issue in the last few weeks of a critical shortage of personal protective equipment (PPE) for doctors and nurses on the frontlines of COVID-19 treatment, the minister said the supply problems are being addressed by actively engaging with thousands of companies, including 159 United Kingdom manufacturers.
Sarah Gilbert, a professor of vaccinology at Oxford, had earlier said the inoculation being developed by her team could be ready for use as early as September.